!-- Global site tag (gtag.js) - Google Analytics -->


Watch our talks, presentations and interviews with the team, discover more about the psychedelic industry.


August 12, 2021

Entheon Biomedical gets sponsorship from Heading Health for ketamine study

Read Now
Business Insider
August 11, 2021

What Do You Really Know About Psychedelics And Psychedelics Stocks?

Read Now
Healthcare Global
August 9, 2021

People moves: Omada, Softheon, Entheon & Zocdoc

Read Now
August 3, 2021

Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies

Read Now
Psychedelic Integration by Lucy Baldwin
July 12, 2021

Timothy Ko explores the neurophysiological benefits of DMT therapy on those suffering addiction,

Read Now
Psychedelic Review
July 9, 2021

Genetic Determinants of the LSD Response - Psychedelic Science Review (psychedelicreview.com)

Read Now


CSE TV - Investing in Psychedelics with Entheon Biomedical | Presented by CSE and CFN Media
CSE TV - Therapeutic Applications of Psychedelics | Investing in Psychedelics Presented by CSE and CFN Media
PSYCHED Studio - Timothy Ko - Why DMT? Treating Substance Abuse Disorder With the "God Molecule"
Benzinga Cannabis Capital Conference

Talk directly to IR

Please enter your information to receive our investor package or reach out to us directly using the information below.

Joseph Cullen
Investor Relations

+1 (778) 919-8615

Please remember our office hours are in Pacific Time (GMT-8, Vancouver - BC, Canada)
By submitting this form you agree to receive communications from Entheon Biomedical. We commit to never selling your data and to keep your information safe. Read our Privacy Policy.
Thank you!
We will contact you soon.
Oops! Something went wrong while submitting the form.